ZEISS Unveils New Ophthalmic Surgery Technologies in Mexico Following COFEPRIS Approval

Introduction

In an exciting development for the field of ophthalmology, ZEISS Medical Technology has received crucial approval from Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) for their innovative ARTEVO® 850 surgical microscope and MICOR® 700 handheld lens removal device. These technologies promise to enhance surgical workflows, improve patient outcomes, and elevate the overall efficiency of cataract surgeries across the country.

Advances in Ophthalmic Surgeries

ZEISS’s ARTEVO 850 is designed to provide ophthalmic surgeons with advanced 3D visualization capabilities, redefining how surgeries are performed. This surgical microscope sets itself apart with its true color imaging and an increased depth of field by nearly 60%. Such enhancements ensure that surgeons can make more informed decisions during delicate procedures. Moreover, the integration of various devices with the microscope allows for a seamless transition between different stages of surgical workflows, facilitating an optimized operational experience.

One of the standout features of the ARTEVO 850 is its user-friendly interface. The controls are consolidated onto a single touchscreen, offering surgical teams intuitive access and thereby minimizing the time taken to switch between functionalities. This innovation is crucial in high-pressure environments like operating rooms where every second counts.

Revolutionizing Cataract Surgery with MICOR 700

Complementing the ARTEVO 850, ZEISS’s MICOR 700 brings a new approach to lens extraction. This handheld device is the first of its kind to operate without ultrasound, allowing surgeons to remove lenses with greater precision and less risk to surrounding tissues. The MICOR 700 utilizes ZEISS's NULEX (non-ultrasonic lens extraction) procedure, which significantly broadens intraocular working space. By minimizing mechanical stress on delicate eye structures, the MICOR 700 showcases a commitment to both safety and efficiency in the operating room.

The design of the MICOR 700 emphasizes gentle handling, featuring a blunt tip with rounded edges that minimizes the risk of tissue damage during surgery. This is particularly important as even minor errors in the operating environment could lead to significant complications for patients. The MICOR 700 also incorporates a disposable “plug-and-play” system, enhancing convenience and ensuring a hygienic approach to surgical procedures.

Impact on Mexican Healthcare

ZEISS aims to empower local surgeons in Mexico by providing them with cutting-edge technology that enhances their surgical capabilities. As highlighted by PT Cheong, the Head of Global Sales for Ophthalmology at ZEISS Medical Technology, the introduction of these advanced tools corresponds directly with ZEISS's ongoing investment in regional markets. This initiative not only fosters personal growth among medical professionals but also contributes to improved patient care in Mexico.

Frank Seitzinger, Head of the Business Sector Surgery Anterior Segment for ZEISS Medical Technology, emphasizes that these surgical instruments serve as 'game changers' in cataract surgery. They elevate the surgeon's ability to control and execute procedures efficiently, thus enabling them to deliver better care for their patients.

Upcoming Showcase at SMO

Both the ARTEVO 850 and the MICOR 700 will be on display at the upcoming XXXVIII Mexican Congress of Ophthalmology (SMO) in Monterrey, Mexico, from May 30 to June 3, 2026. This event provides an excellent opportunity for ophthalmologists and surgical professionals from across the country to experience firsthand the innovations that ZEISS brings to the table.

Conclusion

The addition of the ARTEVO 850 and MICOR 700 to ZEISS’s portfolio represents a significant advancement in ophthalmic surgery technology. With the potential to transform the cataract surgical landscape in Mexico, these tools are poised to enhance both the efficiency of operations and the safety of patients. For more information on ZEISS ophthalmic workflow solutions in Mexico, interested parties can visit their official website.

Final Thoughts

As technology continues to evolve, ZEISS remains committed to leading the charge in medical innovations that enhance the quality of care. By focusing on local markets, the company not only supports healthcare professionals but also reinforces its role as a vital player in the global medical technology arena.